AstraZeneca Pharma stock price jumped by 11% when WHO approved emergency use of COVID-19 vaccines. The company’s share price unexpectedly rose to 11 percent in the early trade of February 16,2021.
AstraZeneca Pharma quoted share price of Rs 3,869.95 at 09:17 hrs on February 16. The stock price was up by 6.59 percent or Rs 239.20 on the BSE.
As of now, the scrip is trading 22.13 percent down on its 52-week high and on the upside it is 104.98% ahead of its 52-week low.
The scrip has hit its 52-week high of Rs 4,970 on September 08, 2020. It touched its 52-week low of Rs 1,888 on March 23, 2020.
World Health Organization has given emergency use approval to the company’s Covid-19 vaccines yesterday.
The WHO has allowed the distribution of Covid-19 vaccines to some specific countries beginning with the poorest countries first.
Moreover, the WHO has listed two different versions of the AstraZeneca-Oxford Covid-19 vaccine. It has given a green signal for these vaccines rolling out globally via Covax.
Also, it is important to know that there are two versions of the vaccine. Both the versions are being produced by Serum Institute of India and South Korea.
Further, the UN health agency’s emergency use listing procedure monitors the quality, safety and also the efficiency of the Covid-19 vaccines.
Check all the recent news updates and share market updates